Étienne Dardenne

2.0k total citations
14 papers, 717 citations indexed

About

Étienne Dardenne is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Étienne Dardenne has authored 14 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Étienne Dardenne's work include RNA Research and Splicing (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (3 papers). Étienne Dardenne is often cited by papers focused on RNA Research and Splicing (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (3 papers). Étienne Dardenne collaborates with scholars based in United States, France and Spain. Étienne Dardenne's co-authors include Lise Gratadou, Martin Dutertre, Didier Auboeuf, Sophie Germann, Eleonora Zonta, Micaela Polay Espinoza, Samaan Samaan, Hussein Mortada, Rosette Lidereau and Keltouma Driouch and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Étienne Dardenne

14 papers receiving 710 citations

Peers

Countries citing papers authored by Étienne Dardenne

Since Specialization

Citations

This map shows the geographic impact of Étienne Dardenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Étienne Dardenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Étienne Dardenne more than expected).

Fields of papers citing papers by Étienne Dardenne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Étienne Dardenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Étienne Dardenne. The network helps show where Étienne Dardenne may publish in the future.

Co-authorship network of co-authors of Étienne Dardenne

This figure shows the co-authorship network connecting the top 25 collaborators of Étienne Dardenne. A scholar is included among the top collaborators of Étienne Dardenne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Étienne Dardenne. Étienne Dardenne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Abstract 1229: BDTX-1535: A MasterKey EGFR inhibitor targeting classical and non-classical oncogenic driver mutations and the C797S acquired resistance mutation to address the evolving molecular landscape of EGFR mutant NSCLC 2024 ·Cancer Research ·Étienne Dardenne, Matthew O’Connor, Monique B. Nilsson, Junqin He, Xiaoxing Yu, John V. Heymach, Xiuning Le, Elizabeth Buck	2
2	Current and emerging therapies for Achondroplasia: The dawn of precision medicine 2023 ·Bioorganic & Medicinal Chemistry ·Étienne Dardenne, Noboru Ishiyama, (unknown), Matthew C. Lucas	6
3	35MO Discovery and characterization of selective, FGFR1-sparing, inhibitors of FGFR2/3 oncogenic mutations for the treatment of cancers 2021 ·Annals of Oncology ·Étienne Dardenne, (unknown), (unknown), Shao Ning Yang, Ahmet Mentes, Luisa Shin Ogawa, (unknown), Anthony F. Trombino, Sherri Smith, Darlene Romashko, Noboru Ishiyama, (unknown), Shalabh Thakur, Edward Rosfjord, Elizabeth Buck, (unknown), Matthew C. Lucas, (unknown)	1
4	Abstract P246: Discovery and characterization of selective, FGFR1 sparing, inhibitors of FGFR2/3 oncogenic mutations for the treatment of cancers 2021 ·Molecular Cancer Therapeutics ·Étienne Dardenne, Fernando Padilla, (unknown), Shao Ning Yang, Ahmet Mentes, Luisa Shin Ogawa, Anthony F. Trombino, Darlene Romashko, (unknown), Shalabh Thakur, Elisabeth Buck, Christopher Roberts, Matthew C. Lucas, (unknown)	1
5	N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer 2019 ·Journal of Clinical Investigation ·Adeline Berger, Nicholas J. Brady, Rohan Bareja, Brian Robinson, Vincenza Conteduca, Michael A. Augello, Loredana Puca, Adnan Ahmed, Étienne Dardenne, Xiaodong Lü, Inah Hwang, (unknown), Andrea Sboner, Olivier Elemento, Jihye Paik, Jindan Yu, Christopher E. Barbieri, Noah Dephoure, Himisha Beltran, David S. Rickman	116
6	Abstract 1947: Rovalpituzumab tesirine as a therapeutic agent for neuroendocrine prostate cancer 2018 ·Cancer Research ·Loredana Puca, (unknown), (unknown), Étienne Dardenne, Kumiko Isse, Michael Sigouros, David M. Nanus, Scott T. Tagawa, Juan Miguel Mosquera, Laura R. Saunders, Himisha Beltran	2
7	Abstract 2792: The small molecule imipridone ONC201 is active in tumor types with dysregulation of the DRD2 pathway 2017 ·Cancer Research ·Neel S. Madhukar, Varun V. Prabhu, Étienne Dardenne, (unknown), (unknown), Rohinton S. Tarapore, Mathew J. Garnett, Ultan McDermott, Cyril H. Benes, Wolfgang Oster, Wafik S. El‐Deiry, Mark N. Stein, David S. Rickman, Joshua E. Allen, Olivier Elemento	2
8	A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors 2016 ·Cell Reports ·Kaitlyn Gayvert, Étienne Dardenne, Cynthia Cheung, Mary Regina Boland, Tal Lorberbaum, (unknown), Yu Chen, Mark A. Rubin, Nicholas P. Tatonetti, David S. Rickman, Olivier Elemento	31
9	RNA Helicases DDX5 and DDX17 Dynamically Orchestrate Transcription, miRNA, and Splicing Programs in Cell Differentiation 2014 ·Cell Reports ·Étienne Dardenne, Micaela Polay Espinoza, Laurent Fattet, Sophie Germann, Marie-Pierre Lambert, Helen Neil, Eleonora Zonta, Hussein Mortada, Lise Gratadou, Mathieu Deygas, Fatima Zahra Chakrama, Samaan Samaan, François-Olivier Desmet, Léon-Charles Tranchevent, Martin Dutertre, Ruth Rimokh, Cyril F. Bourgeois, Didier Auboeuf	156
10	The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways 2013 ·Nucleic Acids Research ·Samaan Samaan, Léon-Charles Tranchevent, Étienne Dardenne, Micaela Polay Espinoza, Eleonora Zonta, Sophie Germann, Lise Gratadou, Martin Dutertre, Didier Auboeuf	44
11	Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness 2012 ·Nature Structural & Molecular Biology ·Étienne Dardenne, Sandra Pierredon, Keltouma Driouch, Lise Gratadou, Magali Lacroix‐Triki, Micaela Polay Espinoza, Eleonora Zonta, Sophie Germann, Hussein Mortada, Jean-Philippe Villemin, Martin Dutertre, Rosette Lidereau, Stéphan Vagner, Didier Auboeuf	105
12	Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor 2012 ·Oncogene ·Sophie Germann, Lise Gratadou, Eleonora Zonta, Étienne Dardenne, (unknown), (unknown), Simon Samaan, Martin Dutertre, Sébastien Jauliac, Didier Auboeuf	59
13	Estrogen Regulation and Physiopathologic Significance of Alternative Promoters in Breast Cancer 2010 ·Cancer Research ·Martin Dutertre, Lise Gratadou, Étienne Dardenne, Sophie Germann, Samaan Samaan, Rosette Lidereau, Keltouma Driouch, Pierre de la Grange, Didier Auboeuf	65
14	Cotranscriptional exon skipping in the genotoxic stress response 2010 ·Nature Structural & Molecular Biology ·Martin Dutertre, Gabriel Sanchez, Marie‐Cécile De Cian, Jérôme Barbier, Étienne Dardenne, Lise Gratadou, Gwendal Dujardin, Catherine Le Jossic-Corcos, Laurent Corcos, Didier Auboeuf	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact